# Combined Modality Treatment of Sarcomas of the Extremities

> **NCT01985295** · PHASE1 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 12 (actual)

## Conditions studied

- Sarcoma,Soft Tissue

## Interventions

- **DRUG:** pazopanib

## Key facts

- **NCT ID:** NCT01985295
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2014-08
- **Final completion:** 2014-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01985295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01985295, "Combined Modality Treatment of Sarcomas of the Extremities". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01985295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*